| Year |
Citation |
Score |
| 2008 |
Zhao C, Sun M, Bennani YL, Gopalakrishnan SM, Witte DG, Miller TR, Krueger KM, Browman KE, Thiffault C, Wetter J, Marsh KC, Hancock AA, Esbenshade TA, Cowart MD. The alkaloid conessine and analogues as potent histamine H3 receptor antagonists. Journal of Medicinal Chemistry. 51: 5423-30. PMID 18683917 DOI: 10.1021/Jm8003625 |
0.348 |
|
| 2008 |
Miller TR, Baranowski JL, Estvander BR, Witte DG, Carr TL, Manelli AM, Krueger KM, Cowart MD, Brioni JD, Esbenshade TA. A robust and high-capacity [(35)S]GTPgammaS binding assay for determining antagonist and inverse agonist pharmacological parameters of histamine H(3) receptor ligands. Assay and Drug Development Technologies. 6: 339-49. PMID 18593375 DOI: 10.1089/adt.2007.118 |
0.304 |
|
| 2006 |
Witte DG, Yao BB, Miller TR, Carr TL, Cassar S, Sharma R, Faghih R, Surber BW, Esbenshade TA, Hancock AA, Krueger KM. Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand. British Journal of Pharmacology. 148: 657-70. PMID 16715122 DOI: 10.1038/sj.bjp.0706752 |
0.312 |
|
| 2005 |
Krueger KM, Witte DG, Ireland-Denny L, Miller TR, Baranowski JL, Buckner S, Milicic I, Esbenshade TA, Hancock AA. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations. The Journal of Pharmacology and Experimental Therapeutics. 314: 271-81. PMID 15821027 DOI: 10.1124/jpet.104.078865 |
0.37 |
|
| 2005 |
Esbenshade TA, Fox GB, Krueger KM, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan L, Wetter J, Marsh K, Bennani YL, Cowart MD, Sullivan JP, Hancock AA. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties. The Journal of Pharmacology and Experimental Therapeutics. 313: 165-75. PMID 15608078 DOI: 10.1124/jpet.104.078303 |
0.345 |
|
| 2004 |
Hancock AA, Diehl MS, Faghih R, Bush EN, Krueger KM, Krishna G, Miller TR, Wilcox DM, Nguyen P, Pratt JK, Cowart MD, Esbenshade TA, Jacobson PB. In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonists. Basic & Clinical Pharmacology & Toxicology. 95: 144-52. PMID 15447739 DOI: 10.1111/j.1742-7843.2004.950307.x |
0.301 |
|
| 2004 |
Esbenshade TA, Fox GB, Krueger KM, Baranowski JL, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan JB, Faghih R, Bennani YL, Williams M, Hancock AA. Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist. Biochemical Pharmacology. 68: 933-45. PMID 15294456 DOI: 10.1016/J.Bcp.2004.05.048 |
0.324 |
|
| 2004 |
Hancock AA, Bennani YL, Bush EN, Esbenshade TA, Faghih R, Fox GB, Jacobson P, Knourek-Segel V, Krueger KM, Nuss ME, Pan JB, Shapiro R, Witte DG, Yao BB. Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist. European Journal of Pharmacology. 487: 183-97. PMID 15033391 DOI: 10.1016/j.ejphar.2004.01.015 |
0.349 |
|
| 2003 |
Hancock AA, Esbenshade TA, Krueger KM, Yao BB. Genetic and pharmacological aspects of histamine H3 receptor heterogeneity. Life Sciences. 73: 3043-72. PMID 14550847 DOI: 10.1016/j.lfs.2003.06.003 |
0.434 |
|
| 1998 |
Lefkowitz RJ, Pitcher J, Krueger K, Daaka Y. Mechanisms of beta-adrenergic receptor desensitization and resensitization. Advances in Pharmacology (San Diego, Calif.). 42: 416-20. PMID 9327928 DOI: 10.1016/S1054-3589(08)60777-2 |
0.513 |
|
| 1997 |
Lefkowitz RJ, Pitcher J, Krueger K, Daaka Y. Mechanisms of β-Adrenergic Receptor Desensitization and Resensitization Advances in Pharmacology. 42: 416-420. DOI: 10.1016/S1054-3589(08)60777-2 |
0.533 |
|
| 1995 |
Krueger KE. Molecular and functional properties of mitochondrial benzodiazepine receptors Bba - Reviews On Biomembranes. 1241: 453-470. PMID 8547305 DOI: 10.1016/0304-4157(95)00016-X |
0.336 |
|
| 1992 |
Krueger KE, Papadopoulos V. Mitochondrial benzodiazepine receptors and the regulation of steroid biosynthesis Annual Review of Pharmacology and Toxicology. 32: 211-237. PMID 1318670 DOI: 10.1146/Annurev.Pa.32.040192.001235 |
0.3 |
|
| 1991 |
Krueger KE. Peripheral-type benzodiazepine receptors: A second site of action for benzodiazepines Neuropsychopharmacology. 4: 237-244. PMID 1678259 |
0.328 |
|
| 1989 |
Kozikowski AP, Tückmantel W, Krueger K. Synthesis of a biotin conjugate of the PCP analogue "metaphit" for potential use in NMDA/PCP receptor isolation Tetrahedron Letters. 30: 4613-4616. DOI: 10.1016/S0040-4039(01)80756-5 |
0.369 |
|
| Show low-probability matches. |